Companies House 14476102 2025-11-30 2025-11-30 2024-12-01 false iso4217:GBP xbrli:pure 14476102 2023-12-01 2024-11-30 14476102 2025-11-30 14476102 2024-12-01 2025-11-30 14476102 2024-11-30 14476102 curr:PoundSterling 2024-12-01 2025-11-30 14476102 uk-bus:CompanyLimitedByGuarantee 2024-12-01 2025-11-30 14476102 uk-bus:FRS102 2024-12-01 2025-11-30 14476102 uk-bus:AuditExempt-NoAccountantsReport 2024-12-01 2025-11-30 14476102 uk-bus:FullAccounts 2024-12-01 2025-11-30 14476102 uk-bus:RegisteredOffice 2024-12-01 2025-11-30 14476102 uk-bus:Director1 2024-12-01 2025-11-30 14476102 uk-bus:Director2 2024-12-01 2025-11-30 14476102 uk-bus:Director3 2024-12-01 2025-11-30 14476102 uk-bus:Director4 2024-12-01 2025-11-30 14476102 uk-bus:Director5 2024-12-01 2025-11-30 14476102 uk-bus:Director6 2024-12-01 2025-11-30 14476102 uk-bus:Director7 2024-12-01 2025-11-30 14476102 uk-bus:Director8 2024-12-01 2025-11-30 14476102 uk-bus:Director9 2024-12-01 2025-11-30 14476102 uk-bus:Director10 2024-12-01 2025-11-30 14476102 uk-bus:Director11 2024-12-01 2025-11-30 14476102 uk-bus:Director12 2024-12-01 2025-11-30 14476102 uk-bus:Director13 2024-12-01 2025-11-30 14476102 uk-bus:Director14 2024-12-01 2025-11-30 14476102 uk-bus:Director15 2024-12-01 2025-11-30 14476102 uk-bus:Director16 2024-12-01 2025-11-30 14476102 uk-bus:Director17 2024-12-01 2025-11-30 14476102 uk-bus:Director18 2024-12-01 2025-11-30 14476102 uk-bus:Director19 2024-12-01 2025-11-30 14476102 uk-bus:Director20 2024-12-01 2025-11-30 14476102 uk-bus:Director21 2024-12-01 2025-11-30 14476102 uk-bus:CompanySecretary1 2024-12-01 2025-11-30 14476102 core:AfterOneYear 2025-11-30 14476102 core:AfterOneYear 2024-11-30 14476102 core:WithinOneYear 2025-11-30 14476102 core:WithinOneYear 2024-11-30 14476102 core:WithinOneYear 2024-12-01 2025-11-30 14476102 core:AfterOneYear 2025-11-30 14476102 core:AfterOneYear 2024-11-30 14476102 core:AfterOneYear 2024-12-01 2025-11-30 14476102 core:ShareCapital 2025-11-30 14476102 core:ShareCapital 2024-11-30 14476102 core:SharePremium 2025-11-30 14476102 core:SharePremium 2024-11-30 14476102 core:OtherReservesSubtotal 2025-11-30 14476102 core:OtherReservesSubtotal 2024-11-30 14476102 core:RevaluationReserve 2025-11-30 14476102 core:RevaluationReserve 2024-11-30 14476102 core:RetainedEarningsAccumulatedLosses 2025-11-30 14476102 core:RetainedEarningsAccumulatedLosses 2024-11-30 14476102 1 2024-12-01 2025-11-30 14476102 2 2024-12-01 2025-11-30 14476102 3 2024-12-01 2025-11-30 14476102 core:LandBuildings 2024-12-01 2025-11-30 14476102 core:LandBuildings 2025-11-30 14476102 core:LandBuildings 2023-12-01 2024-11-30 14476102 core:LandBuildings 2024-11-30 14476102 core:PlantMachinery 2024-12-01 2025-11-30 14476102 core:PlantMachinery 2025-11-30 14476102 core:PlantMachinery 2023-12-01 2024-11-30 14476102 core:PlantMachinery 2024-11-30 14476102 core:FurnitureFittingsToolsEquipment 2024-12-01 2025-11-30 14476102 core:FurnitureFittingsToolsEquipment 2025-11-30 14476102 core:FurnitureFittingsToolsEquipment 2023-12-01 2024-11-30 14476102 core:FurnitureFittingsToolsEquipment 2024-11-30 14476102 core:OfficeEquipment 2024-12-01 2025-11-30 14476102 core:OfficeEquipment 2025-11-30 14476102 core:OfficeEquipment 2023-12-01 2024-11-30 14476102 core:OfficeEquipment 2024-11-30 14476102 core:Vehicles 2024-12-01 2025-11-30 14476102 core:Vehicles 2025-11-30 14476102 core:Vehicles 2023-12-01 2024-11-30 14476102 core:Vehicles 2024-11-30 14476102 core:NetGoodwill 2024-12-01 2025-11-30 14476102 core:NetGoodwill 2025-11-30 14476102 core:NetGoodwill 2023-12-01 2024-11-30 14476102 core:NetGoodwill 2024-11-30 14476102 core:IntangibleAssetsOtherThanGoodwill 2024-12-01 2025-11-30 14476102 core:IntangibleAssetsOtherThanGoodwill 2025-11-30 14476102 core:IntangibleAssetsOtherThanGoodwill 2023-12-01 2024-11-30 14476102 core:IntangibleAssetsOtherThanGoodwill 2024-11-30

# HEALTHCARE DESIGN LEADERSHIP CIC

## Company limited by guarantee

## Company Registration Number:
14476102 (England and Wales)

## Unaudited statutory accounts for the year ended 30 November 2025

## Period of accounts

## Start date: 1 December 2024

## End date: 30 November 2025

# HEALTHCARE DESIGN LEADERSHIP CIC

## Contents of the Financial Statements

for the Period Ended 30 November 2025

Directors report |
Profit and loss |
Balance sheet |
Additional notes |
Balance sheet notes |
Community Interest Report |

# HEALTHCARE DESIGN LEADERSHIP CIC

Directors' report period ended 30 November 2025

The directors present their report with the financial statements of the company for the period ended 30 November 2025

Principal activities of the company

The principal activity of the company is the provision of training and education services

Additional information

The directors present their report and the financial statements for the period from 1st December 2024 to 30th November 2025. Incorporation - The company was incorporated on 10 November 2022. Small companies provision statement: This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006. Approved and authorised by the Board on 18/08/2026. Statement of Directors Responsibilities: Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the surplus or deficit of the company for that period. In preparing these financial statements, the directors are required to: select suitable accounting policies and apply them consistently, make judgements and accounting estimates that are reasonable and prudent and prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. Since the year end 30th November 2025, the company has experienced a continued reduction in income due to an absence of bookings for its training courses. As a result, the directors are reviewing the future viability of the company and are considering the future of the company and its operations. At the date of approval of these financial statements, no final decision regarding closure has been made. The directors continue to assess the company’s financial position and available options

Directors

The directors shown below have held office during the whole of the period from
1 December 2024 to 30 November 2025

K J Bradley
R A J Etchell
D J Gibson
A I Handa
N Hobbs

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
18 August 2026

And signed on behalf of the board by:
Name: K J Bradley
Status: Director

# HEALTHCARE DESIGN LEADERSHIP CIC

## Profit And Loss Account

for the Period Ended 30 November 2025

| 2025 | 2024
--- | --- | ---
| £ | £
Turnover: | 0 | 0
Cost of sales: | 0 | 0
Gross profit(or loss): | 0 | 0
Distribution costs: | 0 | 0
Administrative expenses: | ( 539 ) | ( 779 )
Other operating income: | 0 | 0
Operating profit(or loss): | (539) | (779)
Interest receivable and similar income: | 0 | 0
Interest payable and similar charges: | 0 | 0
Profit(or loss) before tax: | (539) | (779)
Profit(or loss) for the financial year: | (539) | (779)

# HEALTHCARE DESIGN LEADERSHIP CIC

## Balance sheet

As at 30 November 2025

| Notes | 2025 | 2024
--- | --- | --- | ---
|  | £ | £
Fixed assets
Intangible assets: |  | 0 | 0
Tangible assets: |  | 0 | 0
Investments: |  | 0 | 0
Total fixed assets: |  | 0 | 0
Current assets
Stocks: |  | 0 | 0
Debtors: | 3 | 234 | 0
Cash at bank and in hand: |  | 601 | 2,234
Investments: |  | 0 | 0
Total current assets: |  | 835 | 2,234
Prepayments and accrued income: |  | 0 | 0
Creditors: amounts falling due within one year: | 4 | ( 15 ) | ( 1,844 )
Net current assets (liabilities): |  | 820 | 390
Total assets less current liabilities: |  | 820 | 390
Creditors: amounts falling due after more than one year: |  | 0 | 0
Provision for liabilities: |  | 0 | 0
Accruals and deferred income: |  | 0 | 0
Total net assets (liabilities): |  | 820 | 390
Members' funds
Profit and loss account: |  | 820 | 390
Total members' funds: |  | 820 | 390

The notes form part of these financial statements

# HEALTHCARE DESIGN LEADERSHIP CIC

## Balance sheet statements

For the year ending 30 November 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 18 August 2026
and signed on behalf of the board by:

Name: K J Bradley
Status: Director

The notes form part of these financial statements

# HEALTHCARE DESIGN LEADERSHIP CIC

## Notes to the Financial Statements

for the Period Ended 30 November 2025

- ## 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

  Turnover policy

  Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of value added tax, returns, rebates and discounts and after eliminating sales within the company. The company recognises revenue when: The amount of revenue can be reliably measured; it is probable that future economic benefits will flow to the entity; and specific criteria have been met for each of the company's activities.

  Other accounting policies

  1. General information: The company is a company limited by guarantee, incorporated in England and Wales, and consequently does not have share capital. Each of the members is liable to contribute an amount not exceeding £1 towards the assets of the company in the event of liquidation. The address of its registered office is: St Piran House Truro Technology Park Heron Way, Newham Truro Cornwall TR1 2XN England 2. Accounting policies: Summary of significant accounting policies and key accounting estimates. The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated. Statement of compliance: These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. Basis of preparation: These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value. Revenue recognition: Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of value added tax, returns, rebates and discounts and after eliminating sales within the company. The company recognises revenue when: The amount of revenue can be reliably measured; it is probable that future economic benefits will flow to the entity; and specific criteria have been met for each of the company's activities. Tax: Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income. The current corporation tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income. Financial instruments: Classification The company holds the following financial instruments: Short term trade and other debtors and creditors, Cash and bank balances. All financial instruments are classified as basic. Recognition and measurement: The company has chosen to apply the recognition and measurement principles in FRS102. Financial instruments are recognised when the company becomes party to the contractual provisions of the instrument and derecognised when in the case of assets, the contractual rights to cash flows from the assets expire or substantially all the risks and rewards of ownership are transferred to another party, or in the case of liabilities, when the company’s obligations are discharged, expire or are cancelled. Except for bank loans, such instruments are initially measured at transaction price, including transaction costs, and are subsequently carried at the undiscounted amount of the cash or other consideration expected to be paid or received, after taking account of impairment adjustments. Bank loans are initially measured at transaction price, including transaction costs, and are subsequently carried at amortised cost using the effective interest method. 3. Staff numbers: The average number of persons employed by the company (including directors) during the period, was 5.

# HEALTHCARE DESIGN LEADERSHIP CIC

## Notes to the Financial Statements

for the Period Ended 30 November 2025

- ## 2. Employees

  | 2025 | 2024
  --- | --- | ---
  Average number of employees during the period | 5 | 5

# HEALTHCARE DESIGN LEADERSHIP CIC

## Notes to the Financial Statements

for the Period Ended 30 November 2025

## 3. Debtors

| 2025 | 2024
--- | --- | ---
| £ | £
Trade debtors | 234 | 0
Total | 234 | 0

# HEALTHCARE DESIGN LEADERSHIP CIC

## Notes to the Financial Statements

for the Period Ended 30 November 2025

## 4. Creditors: amounts falling due within one year note

| 2025 | 2024
--- | --- | ---
| £ | £
Bank loans and overdrafts |  | 969
Trade creditors | 0 | 45
Taxation and social security | 0 | 0
Other creditors | 15 | 830
Total | 15 | 1,844

During the financial year, a director/member loan amounting to £969 was formally waived by MJ Medical and converted into a permanent, non-repayable capital contribution to support the company's community objectives. As of 30th November 2025, the balance outstanding is £Nil.

# COMMUNITY INTEREST ANNUAL REPORT

### HEALTHCARE DESIGN LEADERSHIP CIC

### Company Number: 14476102 (England and Wales)

### Year Ending: 30 November 2025

Company activities and impact

In the financial year from 2024/25 Healthcare Design Leadership has not delivered any on-site or virtual training as a result of financial pressures within the NHS to fund courses. The Directors are reviewing ongoing organisational costs whilst we wait to see if more funding becomes available to support these courses. If not, the CIC may no longer be viable to continue.

Consultation with stakeholders

The HDL partnership continues to consist of a multi-disciplinary faculty of clinicians, healthcare planners, architects, contractors, engineers and researchers, from across the healthcare built environment. When training is delivered it is provided in partnership with NHS teams, from across the healthcare facility from doctors, nurses, physiotherapists and estates professionals. Whilst we ordinarily receive feedback as no courses were delivered in this period we have not received any feedback.

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration has been made by the company during the period. For completeness, the directors wish to disclose that during the period a member of the CIC converted an outstanding debt liability owed by the company into permanent capital. This was a transfer to the company rather than by it, and no consideration passed from the company as a result. The conversion was made in the context of reducing the company's costs and liabilities, no courses having been delivered during the year. By extinguishing the debt, the conversion has removed a liability from the company's balance sheet and ensured that the company holds no outstanding obligations to creditors. Resources that would otherwise have been committed to servicing the debt are instead preserved for the company's community activities. The conversion has also strengthened the company's capital base, placing it in a more stable position from which to sustain and, where circumstances allow, resume its activities for the benefit of the community it serves. The conversion further ensures that the company's remaining resources can be applied to maximum effect should no courses be delivered in the forthcoming financial year.

This report was approved by the board of directors on
18 August 2026

And signed on behalf of the board by:
Name: D Gibson
Status: Director